FDA Fast-Tracks Good Trip With Approved Psychedelic Drugs For Depression

FDA Fast-Tracks Good Trip With Approved Psychedelic Drugs For Depression

Summary

The vouchers cut down the FDA review process from 12 months to one to two months, making psychedelics potentially available by summer 2026.

Description

The vouchers cut down the FDA review process from 12 months to one to two months, making psychedelics potentially available by summer 2026.

Original reporting

AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.

Open original source

Related coverage